DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Shi Q, Sobrero AF, Shields AF. et al.
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2–6.
Chicago: IL. Abstract LBA1 2017
Access:
We do not assume any responsibility for the contents of the web pages of other providers.